AF
DNTH icon

Allworth Financial’s Dianthus Therapeutics DNTH Stock Holding History

Allworth Financial’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.85K Buy
22
+14
+175% +$811 ﹤0.01% 4374
2025
Q4 		$330 Sell
8
-1
-11% -$39 ﹤0.01% 4619
2025
Q3 		$355 Buy
9
+1
+13% +$26 ﹤0.01% 4517
2025
Q2 		$150 Sell
8
-19
-70% -$356 ﹤0.01% 4355
2025
Q1 		$574 Buy
+27
New +$595 ﹤0.01% 3643
2023
Q3 		– Sell
-23
Closed -$285 – 3463
2023
Q2 		$285 Hold
23
– – ﹤0.01% 3031
2023
Q1 		$299 Buy
23
+3
+15% +$33 ﹤0.01% 2942
2022
Q4 		$128 Hold
20
– – ﹤0.01% 2891
2022
Q3 		$0 Buy
+20
New +$548 ﹤0.01% 2758

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Allworth Financial's DNTH Position: Q1 2026 in Review

Allworth Financial increased its Dianthus Therapeutics (DNTH) stake by 175% in Q1 2026, buying an estimated $811 and bringing the position to 22 shares worth $1.85K. The position accounts for ﹤0.01% of the portfolio, ranked #4374.

Allworth Financial first reported a position in DNTH in Q3 2022 and has held it in 9 quarters since. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.

  • Allworth Financial held 22 shares of Dianthus Therapeutics worth $1.85K as of Q1 2026.
  • Allworth Financial bought 14 Dianthus Therapeutics shares in Q1 2026, an estimated $811.
  • Dianthus Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #4374 holding.
  • Allworth Financial first reported a position in Dianthus Therapeutics in Q3 2022 and has held it in 9 quarters since.
  • 241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.